Atlas Trials

Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer

Clinical trial NCT00195091 · TERMINATED

Trial details

NCT number
NCT00195091
Sponsor
Memorial Sloan Kettering Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2003-12-01
Primary completion
2023-03-02
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.